Skip to main content
DHR
NYSE Life Sciences

Danaher Guides Q3 Core Revenue Growth to 2%-3%, Shares Drop 15%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$171.9
Mkt Cap
$142.34B
52W Low
$160.93
52W High
$242.8
52W Position info
6.8% above low
Off High info
29% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DHR is trading near its 52-week low of $160.93 (6.8% above the low).

Summary

Danaher reported a strong Q2 beat but guided Q3 core revenue growth to just 2%-3%, well below the 5.5% growth just posted, citing customer-project timing in bioprocessing. The stock plunged 15% premarket. Full-year EPS guidance was raised slightly to $8.45-$8.60, but the improvement is largely from the earlier-than-expected Masimo acquisition close, not organic strength. Interest expense jumped to $107M from $71M as debt doubled to fund the deal. Bioprocessing orders grew mid-teens, and management expects to exit 2026 at mid-single-digit core growth, but the near-term slowdown is a sharp reset. This follows the Q2 beat reported earlier today, adding the crucial guidance and market reaction.

At the time of this announcement, DHR was trading at $171.90 on NYSE in the Life Sciences sector, with a market capitalization of approximately $142.3B. The 52-week trading range was $160.93 to $242.80. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

DHR - Latest Insights

DHR
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $237.50
Real-time Price: $230.25 info
Change: -$7.25 (-3%) info
Market Cap: $161.988B info
DHR
Oct 21, 2026, 11:24 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $230.83
Real-time Price: $230.25 info
Change: -$0.580 (-0.25%) info
Market Cap: $161.988B info
DHR
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $221.00
Real-time Price: $230.25 info
Change: +$9.25 (+4%) info
Market Cap: $161.988B info
DHR
Oct 20, 2026, 5:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $230.25 info
Change: +$9.05 (+4%) info
Market Cap: $161.988B info
DHR
Oct 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $230.25 info
Change: +$9.05 (+4%) info
Market Cap: $161.988B info